Core Viewpoint - Shanghai Univi Technology Co., Ltd. plans to repurchase part of its A-shares using its own funds, with a total amount between RMB 15 million and RMB 30 million, to be used for cancellation and reduction of registered capital [2][5]. Group 1: Repurchase Plan Details - The repurchase will be conducted through centralized bidding, with a maximum price of RMB 44 per share [2][6]. - The implementation period for the repurchase is set to be within 12 months from the approval date by the shareholders' meeting [2][10]. - The repurchase plan has been approved by the board of directors and the shareholders' meeting held on April 10 and May 13, 2025, respectively [2][5][16]. Group 2: Shareholder Reduction Plans - Major shareholders, including Shanghai Chuangye Jieli Taili Venture Capital Center, plan to reduce their holdings by up to 2,572,172 shares, not exceeding 3% of the total share capital after excluding repurchased shares [3][13]. - As of the report date, the reduction plan has not yet commenced [3][13]. Group 3: Financial Implications - The total amount for the repurchase is estimated to allow for the acquisition of approximately 340,909 to 681,818 shares, representing 0.39% to 0.79% of the current total share capital [8][11]. - The repurchase will be funded entirely by the company's own funds, ensuring that it does not adversely affect the company's debt repayment ability or ongoing operations [10][12]. Group 4: Compliance and Procedures - The company has opened a dedicated securities account for the repurchase, which will only be used for this purpose [3][17]. - The company will notify creditors regarding the repurchase and provide them with the opportunity to claim debts or request guarantees within 45 days of notification [21][22].
上海优宁维生物科技股份有限公司回购报告书